Organogenesis Holdings Inc.ORGO
Price (close)
$1.42
Market cap
$182.7M
P/E
—
Revenue (TTM)
$457.5M
Net income
-$84.2M
Dividend yield
—
1-year total return
-69.7%
Net margin
-18.4%
Revenue growth
6.5%
Debt / equity
—
What Organogenesis Holdings Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $338.3M | $467.4M | $450.9M | $433.1M | $482.0M | $564.2M |
| Net income | $17.2M | $94.2M | $15.5M | $4.9M | $861,000 | $37.0M |
| Free cash flow | -$12.2M | $30.8M | -$9.0M | $6.6M | $4.2M | -$24.5M |
More on ORGO.
- Organogenesis Holdings Inc. summary
- Organogenesis Holdings Inc. financial statements
- Organogenesis Holdings Inc. key metrics
- Organogenesis Holdings Inc. health scores and style box
- Organogenesis Holdings Inc. earnings
- Organogenesis Holdings Inc. dividends
- Organogenesis Holdings Inc. valuation
- Organogenesis Holdings Inc. ownership and insiders
- Organogenesis Holdings Inc. peers
Figures from Organogenesis Holdings Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.